Lupin awarded tentative US FDA approval for sertraline

02 Jan 2007

1

Lupin Ltd has announced that the US FDA has granted tentative approval for its abbreviated new drug application (ANDA) for sertraline hydrochloride tablets in 25mg, 50mg and 100mg dosages. Sertraline hydrochloride is indicated for the treatment of major depressive disorders.

Lupin''s sertraline hydrochloride tablets will be the AB-rated generic equivalent of Pfizer''s Zoloft tablets. Annual sales for the medication in the US during 2006 were approximately $3.1 billion (IMS data).

The company now intends to launch the generic on final approval, which is expected upon expiration of the marketing exclusivity for the product in February 2007. This is Lupin''s eighteenth ANDA approval.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more